NDC 68788-7575

Acyclovir

Acyclovir

Acyclovir is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Preferred Pharmaceuticals, Inc.. The primary component is Acyclovir.

Product ID68788-7575_699cb83f-8a6e-4cf5-8ca5-f6d65c30da12
NDC68788-7575
Product TypeHuman Prescription Drug
Proprietary NameAcyclovir
Generic NameAcyclovir
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2013-11-29
Marketing CategoryANDA / ANDA
Application NumberANDA203834
Labeler NamePreferred Pharmaceuticals, Inc.
Substance NameACYCLOVIR
Active Ingredient Strength800 mg/1
Pharm ClassesDNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 68788-7575-2

21 TABLET in 1 BOTTLE (68788-7575-2)
Marketing Start Date2019-12-27
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68788-7575-5 [68788757505]

Acyclovir TABLET
Marketing CategoryANDA
Application NumberANDA203834
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-12-27

NDC 68788-7575-3 [68788757503]

Acyclovir TABLET
Marketing CategoryANDA
Application NumberANDA203834
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-12-27

NDC 68788-7575-4 [68788757504]

Acyclovir TABLET
Marketing CategoryANDA
Application NumberANDA203834
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-12-27

NDC 68788-7575-6 [68788757506]

Acyclovir TABLET
Marketing CategoryANDA
Application NumberANDA203834
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-12-27

NDC 68788-7575-7 [68788757507]

Acyclovir TABLET
Marketing CategoryANDA
Application NumberANDA203834
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-12-27

NDC 68788-7575-8 [68788757508]

Acyclovir TABLET
Marketing CategoryANDA
Application NumberANDA203834
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-12-27

NDC 68788-7575-2 [68788757502]

Acyclovir TABLET
Marketing CategoryANDA
Application NumberANDA203834
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-12-27

Drug Details

Active Ingredients

IngredientStrength
ACYCLOVIR800 mg/1

Pharmacological Class

  • DNA Polymerase Inhibitors [MoA]
  • Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
  • Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
  • Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
  • Nucleoside Analog [EXT]

NDC Crossover Matching brand name "Acyclovir" or generic name "Acyclovir"

NDCBrand NameGeneric Name
0093-3630Acycloviracyclovir
0093-8940AcyclovirAcyclovir
0093-8943AcyclovirAcyclovir
0093-8947AcyclovirAcyclovir
0143-9657AcyclovirAcyclovir
0143-9658AcyclovirAcyclovir
0168-0825acycloviracyclovir
0378-8700Acycloviracyclovir
0378-8712AcyclovirAcyclovir
0440-6030AcyclovirAcyclovir
0440-7033acycloviracyclovir
0472-0082AcyclovirAcyclovir
0591-1159Acycloviracyclovir
0713-0630AcyclovirAcyclovir
0904-5789ACYCLOVIRACYCLOVIR
0904-5790acycloviracyclovir
10544-039Acycloviracyclovir
10544-089Acycloviracyclovir
10544-101AcyclovirAcyclovir
68071-1841AcyclovirAcyclovir
68071-3155AcyclovirAcyclovir
68071-3222AcyclovirAcyclovir
68071-4528AcyclovirAcyclovir
68071-4559acycloviracyclovir
68071-4345AcyclovirAcyclovir
68084-109AcyclovirAcyclovir
68084-108AcyclovirAcyclovir
68071-4790AcyclovirAcyclovir
68071-4799AcyclovirAcyclovir
68084-107ACYCLOVIRACYCLOVIR
68382-125acycloviracyclovir
68382-049acycloviracyclovir
68382-048acycloviracyclovir
68382-668acycloviracyclovir
68382-126acycloviracyclovir
68382-792acycloviracyclovir
68382-791acycloviracyclovir
68382-992acycloviracyclovir
68462-746acycloviracyclovir
68788-6360acycloviracyclovir
68788-0505AcyclovirAcyclovir
68788-0504AcyclovirAcyclovir
68788-0715AcyclovirAcyclovir
68788-8989acycloviracyclovir
68788-6827ACYCLOVIRACYCLOVIR
68788-7382acycloviracyclovir
68788-7378acycloviracyclovir
68788-9783AcyclovirAcyclovir
68788-7342AcyclovirAcyclovir
68788-9690AcyclovirAcyclovir
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.